UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000010769 |
|---|---|
| Receipt number | R000012591 |
| Scientific Title | Glargine plus Lixisenatide or vildagliptin succeeding to BOT T2DM control evaluation trial in Kobe |
| Date of disclosure of the study information | 2013/06/15 |
| Last modified on | 2019/12/09 13:50:52 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/05/20 22:32:46 | ||
| 2 | Update | 2013/12/26 13:20:24 | ||
| 3 | Update | 2013/12/26 13:24:38 | Anticipated trial start date |
|
| 4 | Update | 2014/02/28 15:14:20 | Key inclusion criteria Key inclusion criteria |
|
| 5 | Update | 2014/02/28 15:16:36 | TEL |
|
| 6 | Update | 2014/05/21 14:49:37 | Recruitment status |
|
| 7 | Update | 2015/03/26 15:17:41 | Last follow-up date Date of closure to data entry |
|
| 8 | Update | 2016/11/21 20:35:53 | Date analysis concluded |
|
| 9 | Update | 2019/11/29 16:12:13 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Organization Organization Address Address Tel |
|
| 10 | Update | 2019/12/09 13:41:06 | Recruitment status Date of IRB |
|
| 11 | Update | 2019/12/09 13:50:52 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
